Suchergebnisse - (Person:"Liu, Geoffrey")

PubPharm (791)

41

Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival : a retrospective, pooled analysis of cohort studies

enthalten in: The lancet. Public health | September 2023

von Fares, A. | Li, Y. | Jiang, M. | +52

42

Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions

enthalten in: Statistical methods in medical research | 2023

von Deng, Y. | Tu, D. | O'Callaghan, C. | +2

43

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

enthalten in: Advances in therapy | 2023

von Liu, G. | Lam, V.

44

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

enthalten in: Advances in therapy | 2023

von Liu, G. | Lam, V.

45

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

enthalten in: Advances in therapy | 2023

von Liu, G. | Lam, V.

46

Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk : Insight From the INTEGRAL-ILCCO Cohort Analysis

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Cheng, C. | Hong, W. | Li, Y. | +44

47

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2023

von Wakelee, H. | Liberman, M. | Kato, T. | +117

CommentIn: Transl Lung Cancer Res. 2023 Nov 30;12(11):2359-2365. - PMID 38090512

48

First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS) : a phase 3, global, multicentre, open-label, randomised controlled study

enthalten in: Lancet (London, England) | 2023

von Lee, S. | Schulz, C. | Prabhash, K. | +23

CommentIn: Lancet. 2023 Aug 5;402(10400):426-427. - PMID 37423230

49

Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2023

von Zeuge, U. | Fares, A. | Soriano, J. | +14

50

Gastrointestinal Dysmotility as the First Manifestation of Myasthenia Gravis

enthalten in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | 2023

von Alnajjar, S. | Idiaquez Rios, J. | Fathi, D. | +2